Studies have shown that anti-inflammatory treatment can relieve fatigue; for example, selective 5-HT reuptake inhibitors exhibit the most beneficial effects in restraining the inflammation markers in patients with depression [39]. Here, HTR5A is linked to depressive symptom measurement.